BioDtech
Birmingham
About BioDtech
Biodtech, Inc. develops and markets a line of reagents and systems for the detection, neutralization, and removal of endotoxin to researchers in bioresearch and bioprocess markets. It offers various detection solutions, including EndoDtec-F, a reagent that is used to uncover bacteria in environmental samples, injectable drugs, and medical devices, as well as on surfaces; sushi Ĕ3 anti-sera that allows investigators to perform independent ELISA and western blot studies; and EndoPrep, a sample treatment system to remove the inhibitory or enhancing effects of proteins, peptides, and antibodies in endotoxin assays. The company also provides EndoBind-R, a removal reagent that removes endotoxins from aqueous samples; EndoZap-R, an endotoxin neutralization peptide that is used as an anti-microbial; endotoxin-free water; and endotoxin detection and removal services. Biodtech, Inc. was founded in 2003 and is based in Birmingham, Alabama.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $575.0K
- Funding stage: M&A
- Last round: Series Unknown (Aug 2010)
- Website: biodtechinc.com
- Phone: 2054147400
Industries & Categories
Biotechnology, Health Care, Nutraceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biodtech-1019233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.